Ignota Labs is driven to transform precision medicines by alleviating safety concerns
At Ignota Labs, we understand that safety failures throughout the drug discovery process can lead to costly setbacks and delays in bringing life-changing therapies to market.
Our interdisciplinary team of world-leading experts in AI, drug discovery and toxicology has created state-of-the-art in silico models that accurately predict key toxicology endpoints.
56% of drug discovery projects fail due to safety
Proactive optimisation of safety alongside your efficacy
Assess your chemistry for safety liabilities before it is expensive to resolve
Turnaround for distressed pharmaceutical assets
Quickly diagnose the root cause of a known problem and find safe alternatives
Analysis for pharmaceutical
in-licensing
Assess your incoming assets for risk quickly and more in-depth than wet-lab tests
Discover how Ignota Labs can help transform your drug discovery process and propel your research towards safer and more effective therapeutic candidates.
Contact us today to learn more about our innovative AI-driven small molecule toxicity prediction and optimisation solutions.